Clinical Trials Logo

Clinical Trial Summary

The aim of the present study is to prospectively evaluate the safety of Edoxaban.


Clinical Trial Description

The aim of the present study is to prospectively evaluate the safety of Edoxaban in daily clinical practice in Spain in elderly patients with nonvalvular atrial fibrillation who meet the criteria for frailty and who have been prescribed the drug recently (<6 months prior to inclusion). The study will provide us with a clear and real-life picture of bleeding and ischemic complications and possible treatment interruptions with Edoxaban in real life and in a large subgroup, although underrepresented in the studies. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05732506
Study type Observational [Patient Registry]
Source Galaxia Empírica
Contact Antonio Domingo Pose Reino
Phone 605680912
Email antonio.pose@usc.es
Status Recruiting
Phase
Start date February 1, 2023
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04133545 - Discontinuation for Oral Anticoagulants in Patients With Atrial Fibrillation